BMEA
BMEA clinical trials: Biomea Fusion, Inc.
Every trial on ClinicalTrials.gov where Biomea Fusion, Inc. is the lead sponsor or a listed collaborator, the trials it leads first, each labelled Lead or Collaborator. Phase, status and dates as registered.
- 9
- Trials linked
- 9
- As lead sponsor
- 0
- As collaborator
- 0
- Primary completions as lead sponsor, next 90 days
BMEA on the catalyst calendar · BMEA registry changes
- Primary completion Nov 18, 2024ActualPhase 1/Phase 2NCT05731544Study of BMF-219 in Healthy Adult Subjects and in Adult Subjects With Type 2 Diabetes Mellitus (T2D)Biomea Fusion Inc. · Type 2 Diabetes MellitusCompletedBMEALead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Aug 12, 2026ActualPhase 1NCT07223216Study of BMF-650 in Otherwise Healthy Overweight or Obese Adult ParticipantsBiomea Fusion Inc. · ObesityCompletedBMEALead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jun 2027Sponsor estimatePhase 2NCT07502508Phase 2 Trial of Icovamenib in Participants With Type 2 Diabetes Mellitus Who Are Not Achieving Glycemic Targets While Using GLP-1-Based...Biomea Fusion Inc. · Type 2 DiabetesRecruitingBMEALead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jan 1, 2026ActualPhase 1NCT05918692A Phase 1 Study of BMF-500 in Adults With Acute LeukemiaBiomea Fusion Inc. · Acute Myeloid LeukemiaCompletedBMEALead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Mar 2027Sponsor estimatePhase 2NCT07502495Phase 2 Trial of Icovamenib in Participants With Type 2 Diabetes Who Are Not Achieving Glycemic TargetsBiomea Fusion Inc. · Type 2 DiabetesActive, not recruitingBMEALead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion May 20, 2025ActualPhase 2NCT06152042Phase 2 Trial of BMF-219 in Participants With Type 1 Diabetes MellitusBiomea Fusion Inc. · Type 1 Diabetes MellitusCompletedBMEALead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jan 14, 2026ActualPhase 1NCT07254286Food Effect Study in Healthy VolunteersBiomea Fusion Inc. · Healthy VolunteerCompletedBMEALead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Feb 13, 2025ActualPhase 1NCT05153330Study of BMF-219, a Covalent Menin Inhibitor, in Adult Patients With AML, ALL (With KMT2A/ MLL1r, NPM1 Mutations), DLBCL, MM, and CLL/SLLBiomea Fusion Inc. · Acute Myeloid LeukemiaTerminatedBMEALead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jan 15, 2025ActualPhase 1NCT05631574Study of Covalent Menin Inhibitor BMF-219 in Adult Patients With KRAS Driven Non-Small Cell Lung Cancer, Pancreatic Cancer, and...Biomea Fusion Inc. · Non Small Cell Lung CancerTerminatedBMEALead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
Enrollment, interventions and the start and completion dates are locked on 9 rows here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.
Unlock with TrialScanner